Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTransplantation ChimeraStem CellsBone Marrow TransplantationGraft vs Leukemia EffectMyeloablative AgonistsTreatment OutcomeTissue DonorsBusulfanRemission InductionVidarabineRecurrenceGraft vs Tumor EffectGraft SurvivalHistocompatibility TestingLymphocyte TransfusionBone and BonesImmunosuppressive AgentsLeukemia, Myeloid, AcuteMultiple MyelomaLeukemiaRetrospective StudiesHematopoietic Stem CellsSiblingsCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCord Blood Stem Cell TransplantationCytomegalovirus InfectionsMinor Histocompatibility AntigensSalvage TherapyWhole-Body IrradiationDisease-Free SurvivalLiver TransplantationLymphocyte DepletionMyelodysplastic SyndromesSurvival AnalysisAntilymphocyte SerumVirus ActivationNeoplasm, ResidualSurvival RateHistocompatibilityPrecursor Cell Lymphoblastic Leukemia-LymphomaMelphalanChimerismHepatic Veno-Occlusive DiseaseTime FactorsMesenchymal Stem Cell TransplantationCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusHematopoietic Stem Cell MobilizationT-LymphocytesPrimary MyelofibrosisAcute DiseaseAnemia, AplasticCell TransplantationBone MarrowBone Marrow CellsKidney TransplantationFollow-Up StudiesHLA AntigensEmbryonic Stem CellsHematologic DiseasesLeukemia, Myeloid, Accelerated PhaseAntigens, CD34PrognosisAntibodies, NeoplasmTransplantation ImmunologyRoseolovirus InfectionsImmunosuppressionCytarabineBenzamidesAdult Stem CellsLeukemia, MyeloidLymphoproliferative DisordersImmunocompromised HostAntineoplastic AgentsFusion Proteins, bcr-ablReceptors, Purinergic P2X5Hodgkin DiseasePyrimidinesNuclear FamilyGraft RejectionBone RemodelingGranulocyte Colony-Stimulating FactorGanciclovirLymphoma, Non-HodgkinCell DifferentiationInfectionPiperazinesFatal OutcomeCyclosporineImmunotherapy, Adoptive